Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline - Top-Institutions - MDSpire

Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline

  • By

  • Jennifer A Wyckoff

  • Annunziata Lapolla

  • Bernadette D Asias-Dinh

  • Linda A Barbour

  • Florence M Brown

  • Patrick M Catalano

  • Rosa Corcoy

  • Gian Carlo Di Renzo

  • Nancy Drobycki

  • Alexandra Kautzky-Willer

  • M Hassan Murad

  • Melanie Stephenson-Gray

  • Adam G Tabák

  • Emily Weatherup

  • Chloe Zera

  • Naykky Singh-Ospina

  • July 13, 2025

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Joslin Diabetes Center
    Joslin Diabetes Center

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Diabetes Research
    • Maternal-Fetal Medicine

  • #2

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Obstetrics and Gynecology
    • Maternal-Fetal Medicine

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Maternal-Fetal Medicine
    • Diabetes Care

  • #4

    University of Cambridge
    University of Cambridge

    Cambridge, UK

    Key Differentiators

    • Endocrinology
    • Obstetrics
    • Diabetes Research

  • #5

    University of Toronto
    University of Toronto

    Toronto, ON

    Key Differentiators

    • Endocrinology
    • Maternal-Fetal Medicine
    • Diabetes Research

Original Source(s)

Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline

  • by Jennifer A Wyckoff, Annunziata Lapolla, Bernadette D Asias-Dinh, Linda A Barbour, Florence M Brown, Patrick M Catalano, Rosa Corcoy, Gian Carlo Di Renzo, Nancy Drobycki, Alexandra Kautzky-Willer, M Hassan Murad, Melanie Stephenson-Gray, Adam G Tabák, Emily Weatherup, Chloe Zera, Naykky Singh-Ospina

  • July 13, 2025

Related Content

Immune cells and high-density lipoprotein cholesterol derivative markers mediate the impact of hypertriglyceridemia on hyperuricemia in diabetes mellitus

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

Invasive NSTEMI Strategy Shows No Benefit in Frail Patients

Frailty severity may identify older patients least likely to benefit—and potentially at higher risk—with invasive management.